The aim is to seek a balance between income and growth with a medium risk profile.
Name | % Net Assets |
---|---|
BP | 3.2% |
Treasury 5% 07/03/08 | 3.1% |
Elders Merrill Lynch Japan | 2.9% |
GlaxoSmithKline | 2.7% |
Edinburgh Dragon Trust | 2.7% |
CF Morant Wright Japan | 2.6% |
Vodafone | 2.6% |
Serco | 2.4% |
Treasury 2.5% IL 26/07/16 | 2.4% |
Aberdeen Asia Pacific | 2.3% |
Key | % Net Assets |
---|---|
BP | 3.2% |
Treasury 5% 07/03/08 | 3.1% |
Elders Merrill Lynch Japan | 2.9% |
GlaxoSmithKline | 2.7% |
Other | 88.1% |
Date | n/a |
---|---|
Bid | 0.00 |
Offer | 0.00 |
Currency | n/a |
Change | 0.00 |
% | n/a |
YTD change | 0.00 |
YTD % | n/a |
Fund Inception | 19/04/2004 |
---|---|
Fund Manager | n/a |
TER | 3.00 (30-Jun-2013) |
Minimum Investment | |
---|---|
Initial | 25000 |
Additional | 5,000 |
Savings | n/a |
Charges | |
---|---|
Initial | 4.50% |
Annual Mang't | 1.50% |
Exit | n/a |
Name | % |
---|---|
Standard deviation | 0.02 |
Sharpe ratio | 0.03 |
You are here: research